Amarin Corp Plc (AMRN)

[SonamKapoor]

Hedging probably occurs, but on what scale? And it's going to be company to company (= limited data). Yes, O-3 market was growing and seemingly doing well until the 2013 prostate study came out; plus, the patent cliff. Then a barrage of negative press continued to report on even studies with wonky methodologies.

If you haven't heard this 2013 interview with Prof Bill Harris of Univ. of South Dakota on this very topic - it's worth a listen: Bill Harris interview

I hope that R-IT and VITAL turn things around. Nov 10th. Whoop Whoop!

Omega 3's. 30,000+ studies and counting.